GlobeNewsWire
25 Aug 2026, 22:37 UTC · 8w ago
Impact · against what's priced in
Parsons Corporation faces significant fundamental deterioration and legal risk following a massive revenue miss and guidance cuts. Azenta and Abeona Therapeutics are facing new legal scrutiny through investor investigations.
No priced-in read yet
What the story claims
4 claims · scored −1 bearish … +1 bullish
Parsons Corporation lowered its full-year revenue guidance to $6.2B–$6.5B and sharply reduced adjusted EBITDA and cash flow guidance.
More negative than 99% of claims this week
Parsons Corporation reported Q2 2026 revenue of $1.58 billion, missing consensus estimates by $30 billion.
Continue reading
5 related stories
The company missed consensus revenue estimates by $30 billion, lowered full-year revenue guidance to $6.2B–$6.5B, and is now under investigation for potential securities fraud.
Read from the article alone
No priced-in read yet
Pomerantz LLP has launched an investigation into potential securities fraud or unlawful business practices at Abeona Therapeutics.
Read from the article alone
No priced-in read yet
Pomerantz LLP is investigating claims on behalf of investors regarding possible securities fraud at Azenta.
Read from the article alone
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 98% of claims this week
Parsons Corporation divested certain contracts and exited two programs due to staffing, supply-chain, and management challenges.
More negative than 90% of claims this week
Pomerantz LLP is investigating Parsons Corporation for potential securities fraud or unlawful business practices.
More negative than 84% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
Company is facing a securities fraud investigation following a significant revenue miss, guidance cuts, and a 35% stock price drop.
More negative than 74% of ticker scores this week
Company is the subject of an investigation by a law firm on behalf of investors.
More negative than 74% of ticker scores this week
Company is the subject of an investigation by a law firm on behalf of investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Business Wire
5h ago
−27.4%
Price agrees with the score
$4.51 vs $6.21 close before publication (Aug 25) · not market-adjusted
ABEO chart →+10.7%
Price is moving against the score
$36.76 vs $33.21 close before publication (Aug 25) · not market-adjusted
AZTA chart →−5.5%
Price agrees with the score
$45.40 vs $48.04 close before publication (Aug 25) · not market-adjusted
PSN chart →
